Literature DB >> 21224112

Successful treatment of metastatic choriocarcinoma after DMP 840.

C B Pratt1, B N Rao, C F Stewart, J J Jenkins.   

Abstract

A 17-year-old male with retroperitoneal choriocarcinoma metastatic disease in the lungs has had shrinking of pulmonary metastases and primary tumor with four treatment courses of DMP 840. β-HCG appeared normal prior to resection of the necrotic primary tumor and a single remaining pulmonary metastasis, which was also necrotic. The patient remains free of tumor recurrence of 8 months following surgery. Further evaluation of DMP 840 in patients with germ cell tumors is indicated.

Entities:  

Year:  1995        PMID: 21224112     DOI: 10.1016/1078-1439(95)00042-9

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  1 in total

1.  Phase I study of DMP 840 in pediatric patients with refractory solid tumors.

Authors:  J Thompson; C B Pratt; C F Stewart; L Avery; L Bowman; W C Zamboni; A Pappo
Journal:  Invest New Drugs       Date:  1998       Impact factor: 3.850

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.